Related references
Note: Only part of the references are listed.A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis
Yan Wang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210)
Yoshiaki Iwasaki et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
Phase II multi-institutional prospective randomised trial comparing S-1+paclitaxel with S-1+cisplatin in patients with unresectable and/or recurrent advanced gastric cancer
E. Mochiki et al.
BRITISH JOURNAL OF CANCER (2012)
Long-term follow up of patients who were positive for peritoneal lavage cytology: final report from the CCOG0301 study
Yasuhiro Kodera et al.
GASTRIC CANCER (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Japanese classification of gastric carcinoma: 3rd English edition
GASTRIC CANCER (2011)
The Roles of Surgical Oncologists in the New Era - Minimally Invasive Surgery for Early Gastric Cancer and Adjuvant Surgery for Metastatic Gastric Cancer
Kazuhiro Yoshida et al.
PATHOBIOLOGY (2011)
Induction Chemotherapy with S-1 Plus Cisplatin Followed by Surgery for Treatment of Gastric Cancer with Peritoneal Dissemination
Hiroshi Okabe et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
Wasaburo Koizumi et al.
LANCET ONCOLOGY (2008)
Epidemiology of gastric cancer
Katherine D. Crew et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer
W Koizumi et al.
BRITISH JOURNAL OF CANCER (2003)
Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205)
A Ohtsu et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
